We are live on
!
Find out more
NMC
NEA Management Company Portfolio holdings
AUM
$1.76B
1-Year Est. Return
223.33%
This Fund
S&P 500
This Quarter
Est. Return
+30.59%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$2B
AUM Growth
+$56.4M
(+2.9%)
Cap. Flow
+$172M
Cap. Flow
% of AUM
8.6%
Top 10 Holdings %
Top 10 Hldgs %
60.79%
Holding
62
New
5
Increased
3
Reduced
2
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZFOX
ZeroFox Holdings, Inc. Common Stock
ZFOX
|
+$150M |
| 2 |
Gossamer Bio
GOSS
|
+$43M |
| 3 |
ALLK
Allakos
ALLK
|
+$16.7M |
| 4 |
NOTE
FiscalNote
NOTE
|
+$14.2M |
| 5 |
TUYA
Tuya Inc
TUYA
|
+$7.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$27.2M |
| 2 |
Palo Alto Networks
PANW
|
+$17M |
| 3 |
VistaGen Therapeutics
VTGN
|
+$14.3M |
| 4 |
MILE
Metromile, Inc. Common Stock
MILE
|
+$8.61M |
| 5 |
Global E Online
GLBE
|
+$7.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 66.51% |
| 2 | Technology | 14.18% |
| 3 | Industrials | 9.57% |
| 4 | Consumer Staples | 8.54% |
| 5 | Communication Services | 1.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEUE
1
DELISTED
NeueHealth
NEUE
| $229M | 11.44% |
2,727,652
| – | – |
|
2
Coursera
COUR
$1.74B
| $171M | 8.54% |
15,867,769
| – | – |
|
3
IonQ
IONQ
$12.2B
| $134M | 6.67% |
26,350,067
| – | – |
|
|
ACLX
4
DELISTED
Arcellx
ACLX
| $127M | 6.32% |
6,750,264
| – | – |
|
5
Rhythm Pharmaceuticals
RYTM
$7.36B
| $108M | 5.41% |
4,912,306
| – | – |
|
6
CRISPR Therapeutics
CRSP
$4.65B
| $104M | 5.19% |
1,590,002
| – | – |
|
7
Cloudflare
NET
$94.2B
| $104M | 5.18% |
1,877,510
| – | – |
|
|
ZFOX
8
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
| $88.3M | 4.41% |
+18,090,861
| New | +$150M |
|
9
Mirum Pharmaceuticals
MIRM
$6.67B
| $88M | 4.39% |
4,187,801
| – | – |
|
|
BGRY
10
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $65M | 3.24% |
38,226,621
| – | – |
|
11
Monte Rosa Therapeutics
GLUE
$1.85B
| $62.9M | 3.14% |
7,703,205
| – | – |
|
|
VRNA
12
DELISTED
Verona Pharma
VRNA
| $57.1M | 2.85% |
5,584,753
+476,190
| +9% | +$4.01M |
|
13
Nkarta
NKTX
$155M
| $47M | 2.35% |
3,571,640
| – | – |
|
|
14
Gossamer Bio
GOSS
$97M
| $41.5M | 2.07% |
+3,467,406
| New | +$43M |
|
15
Geron
GERN
$917M
| $38.2M | 1.91% |
16,318,681
| – | – |
|
16
Savara
SVRA
$1.08B
| $37.4M | 1.87% |
24,137,931
| – | – |
|
|
DM
17
DELISTED
Desktop Metal, Inc.
DM
| $37.3M | 1.86% |
1,440,759
| – | – |
|
|
ALLK
18
DELISTED
Allakos
ALLK
| $33.9M | 1.69% |
6,148,704
+3,984,000
| +184% | +$16.7M |
|
|
OYST
19
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $33.3M | 1.66% |
5,925,287
| – | – |
|
|
AVEO
20
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $32.5M | 1.62% |
3,952,957
| – | – |
|
21
Aurinia Pharmaceuticals
AUPH
$1.92B
| $29.9M | 1.49% |
3,969,834
| – | – |
|
|
AKUS
22
DELISTED
Akouos Inc
AKUS
| $29.1M | 1.45% |
4,298,488
| – | – |
|
23
BuzzFeed
BZFD
$99.9M
| $23.9M | 1.19% |
3,833,473
| – | – |
|
24
CVRx
CVRX
$133M
| $22.1M | 1.1% |
2,370,858
| – | – |
|
25
NextNav
NN
$1.78B
| $22M | 1.1% |
8,189,156
| – | – |
|
Similar funds
NM
SLF
CCIA
SW
CGH
PWP
CIP
KOCAA
NEA Management Company's Q3 2022 Portfolio in Review
As of Q3 2022, NEA Management Company held 62 positions worth $2B, up 2.9% from $1.95B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
NEA Management Company deployed $172M of net new capital in Q3 2022, opening 5 new positions and adding to 3 existing holdings. Its largest new stake was ZeroFox Holdings, Inc. Common Stock: 18,090,861 shares worth $88.3M.
By sector, the portfolio is most concentrated in Healthcare at 67% of assets, down from 69% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was CTI BioPharma Corp. (DE) Common Stock, an estimated $27.2M trimmed.
- NEA Management Company's largest Q3 2022 buy was ZeroFox Holdings, Inc. Common Stock: 18,090,861 shares worth $88.3M.
- NEA Management Company added most to Allakos in Q3 2022, an estimated $16.7M increase.
- NEA Management Company's biggest Q3 2022 reduction was CTI BioPharma Corp. (DE) Common Stock, cutting an estimated $27.2M.
- NEA Management Company fully exited VistaGen Therapeutics in Q3 2022, selling an estimated $14.3M.
- NEA Management Company's ten largest holdings make up 61% of its $2B portfolio in Q3 2022.
- NEA Management Company opened 5 new positions and closed 5 in Q3 2022.
- NEA Management Company's portfolio value rose 2.9% quarter-over-quarter to $2B.
Based on NEA Management Company's 13F filing for Q3 2022, filed 14 Nov 2022.